C. Civan Et Al. , "The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage," CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.39, no.5, pp.373-380, 2024
Civan, C. Et Al. 2024. The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.39, no.5 , 373-380.
Civan, C., Ozkan, Z. G., Ozkan, B., Isik, E. G., Erdogdu, E., Simsek, D. H., ... Duman, S.(2024). The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.39, no.5, 373-380.
Civan, Caner Et Al. "The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage," CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.39, no.5, 373-380, 2024
Civan, Caner Et Al. "The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.39, no.5, pp.373-380, 2024
Civan, C. Et Al. (2024) . "The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.39, no.5, pp.373-380.
@article{article, author={Caner CİVAN Et Al. }, title={The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage}, journal={CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS}, year=2024, pages={373-380} }